Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects

Field Value
Model ID11-038-01
Model NameDorresteijn 2011
Pubmed ID22090661
First AuthorDorresteijn
JournalEuropean Heart Journal
Year2011
TitleAspirin for primary prevention of vascular events in women: individualized prediction of treatment effects
Primary Index ConditionPopulation Sample
Secondary Index ConditionN/A
OutcomeMACCE
Model Sample Size27939
Cohort Sample Size27939
Number of Events652
Follow-Up DurationLong (>6 months)
AUROC0.78
Calibration Reported1
CovariatesIntercept; Age in years; Age if using aspirin; Current smoker; Current smoker and using aspirin; Systolic blood pressure in mmHg; Total cholesterol in mmol/L; HDL cholesterol in mmol/L; High-sensitivity C-reactive protein in mg/dL; High-sensitivity C-reactive protein if using aspirin; Blood pressure lowering medication; Positive family history for premature myocardial infarction; Hemoglobin A1C (%) if diabetic; Aspirin; Body mass index (kg/m^2) if using aspirin
Mesh TermsTo be updated
Number of Validations0

External Validations